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Three decades ago, President Gerald Ford signed the federal Toxic 
Substances Control Act (TSCA 1976) to restrict or ban the use of 
toxic chemicals. The world has changed remarkably since the incep-
tion of TSCA. There are new chemicals and materials today, includ-
ing those created using nano  technology—only a dream in 1976. Our 
understanding of chemi  cal hazards and the techniques used to evaluate 
potential toxicity have evolved significantly. Now, with this confluence 
of knowledge and technology, there is broad consensus from a diverse 
group of federal agencies and other interested parties that the nation is 
ready to pursue a fresh perspective on chemical evaluation.
To jump-start the discussion on TSCA reform, the U.S. Senate 
Committee on Environment and Public Works convened a hear-
ing on 2 December 2009. Lisa Jackson, Administrator of the U.S. 
Environmental Protection Agency (EPA); John Stephenson, Director 
of the U.S. Government Accountability Office Natural Resources and 
Environment; and I testified to the Committee chaired by Senator 
Barbara Boxer of California (U.S. Senate Committee on Environment 
and Public Works 2009). My peers’ remarks focused on principles for 
TSCA reform based on industry participation and expansion of the 
U.S. EPA’s authorities. My primary goal was to inform law  makers 
of the progress in environmental health science, which has made 
tremendous strides due in part to the advancements achieved by the 
National Institute of Environmental Health Sciences (NIEHS) and 
the National Toxicology Program (NTP). These advancements, along 
with critical partnerships between agencies, can set the groundwork for 
a major shift in evaluating and regulating the safety of tens of thou-
sands of chemicals.
Research has shown that the normal development of the fetus, 
infant, and child can be disrupted by relatively low doses of certain 
chemicals. These developmental stages are “windows of susceptibility” 
when there is increased vulnerability to the effects of toxic chemicals. 
This concept was first established for neuro  developmental toxicants 
such as poly  chlorinated biphenyls (PCBs), lead, mercury, and other 
metals, but it also applies to hormonally active agents such as bis-
phenol A, an endocrine-disrupting chemical. For example, researchers 
at the Breast Cancer and Environment Research Program (cofunded 
by the NIEHS and the National Cancer Institute) are determining 
whether windows of susceptibility exist in the development of the 
mammary gland, and if exposures to environmental agents during 
these vulnerable periods of development increase the risk for breast 
cancer in adulthood. This new understanding heightens the need to 
protect our children from dangerous substances at critical times in 
their development.
Toxicity research must extend to health end points beyond those 
traditionally emphasized—namely, cancer and birth defects. For exam-
ple, the NIEHS is supporting research on the origins of obesity and 
the theory that environmental exposures during a child’s develop  ment 
play an important role in the current epidemic of obesity, diabetes, and 
metabolic syndrome. There are data showing weight gain in rats and 
mice after develop  mental exposure to a number of different substances, 
so we need to start thinking about obesity, not just in terms of genetics 
and lifestyle, but also in terms of environmental chemicals. These kinds 
of health outcomes need to be considered in assessing toxicity.
Furthermore, all of us are exposed to many different chemicals at 
the same time, not just one chemical at a time the way they are usu-
ally tested in the laboratory (and currently approved for use). Scientists 
have successfully estimated risk from combinations of exposures. One 
example was the method used for dioxin, a known human carcinogen, 
and related compounds such as furans and some PCBs. A method was 
developed to estimate toxicity of mixtures of dioxin-like compounds 
based on toxic equivalency factors (TEFs). 
The methodology was tested and confirmed 
by the NTP, the U.S. EPA, and others. The 
TEF methodology is also applied to other 
health end points, including reproductive, 
developmental, immune, and neurologic outcomes. The question for 
public health officials is how health standards can be adjusted to take 
into account the fact that people are always exposed to mixtures of com-
pounds, not individual chemicals in isolation.
The route of exposure must also be considered. For example, initial 
studies on the inhalation of hexavalent chromium showed it causes lung 
cancer in humans, but there was concern over its presence in drinking 
water and the safety of ingesting the chemical. Additional studies by the 
NTP showed that oral consumption of hexavalent chromium causes 
cancer in laboratory animals, at concentrations that are not that much 
higher than what can be found in people. Thus, although there is a clear 
need to test different routes of chemical exposure when assessing toxic-
ity, it is equally important to focus on the internal dose of the chemical 
in order to compare animals and people. 
TSCA reform can be built upon vastly improved and less expensive 
toxicologic testing methods. The NTP is laying the foundation for this 
testing paradigm in partnership with the National Human Genome 
Research Institute and the U.S. EPA. The new methods use quantita-
tive high-throughput screening assays to test a large number of chemi-
cals simultaneously, dramatically increasing the rate at which chemicals 
can be prioritized for further testing.
Over the past 33 years we have significantly expanded our under-
standing of chemical exposures and health. We now have the ability 
to apply new technologies and our growing knowledge to more accu-
rately address the risks of dangerous toxic chemicals. This provides a 
firm foundation for a comprehensive safety system our citizens deserve 
under a revitalized TSCA. 
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